Englander Institute for Precision Medicine
Found 797 results
Author Title Type [ Year(Asc)]
Filters: Clinical-trials-corner-issue-10(1) is   [Clear All Filters]
2020
Hensler M, Kasikova L, Fiser K, Rakova J, Skapa P, Laco J, Lanickova T, Pecen L, Truxova I, Vosahlikova S et al..  2020.  M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.. J Immunother Cancer. 8(2)
Gilvary C, Elkhader J, Madhukar N, Henchcliffe C, Goncalves MD, Elemento O.  2020.  A machine learning and network framework to discover new indications for small molecules.. PLoS Comput Biol. 16(8):e1008098.
Punjani N, Lamb DJ.  2020.  Male infertility and genitourinary birth defects: there is more than meets the eye.. Fertil Steril. 114(2):209-218.
Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N et al..  2020.  Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.. Eur Urol. 77(4):508-547.
Ricketts C, Seidman D, Popic V, Hormozdiari F, Batzoglou S, Hajirasouliha I.  2020.  Meltos: multi-sample tumor phylogeny reconstruction for structural variants.. Bioinformatics. 36(4):1082-1090.
Yamazaki T, Galluzzi L.  2020.  Mitochondrial control of innate immune signaling by irradiated cancer cells.. Oncoimmunology. 9(1):1797292.
Yamazaki T, Kirchmair A, Sato A, Buqué A, Rybstein M, Petroni G, Bloy N, Finotello F, Stafford L, Manzano ENavarro et al..  2020.  Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.. Nat Immunol. 21(10):1160-1171.
Hassler MR, Bray F, Catto JWF, Grollman AP, Hartmann A, Margulis V, Matin SF, Roupret M, Sfakianos JP, Shariat SF et al..  2020.  Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature.. Eur Urol. 78(2):209-220.
Matrai C, Motanagh S, Mirabelli S, Ma L, He B, Chapman-Davis E, Kurtis B, Elemento O, Mosquera JMiguel, Ellenson LH.  2020.  Molecular Profiles of Mixed Endometrial Carcinoma.. Am J Surg Pathol. 44(8):1104-1111.
Shah MA, Enzinger P, Ko AH, Ocean AJ, Philip PAgop, Thakkar PV, Cleveland K, Lu Y, Kortmansky J, Christos PJ et al..  2020.  Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome.. Clin Cancer Res. 26(18):4756-4766.
Melis M, Zhang T, Scognamiglio T, Gudas LJ.  2020.  Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma.. Carcinogenesis. 41(11):1553-1564.
Fulmer CG, Park K, Dilcher T, Ho M, Mirabelli S, Alperstein S, Hissong EM, Pittman M, Siddiqui M, Heymann JJ et al..  2020.  Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study.. Cancer Cytopathol. 128(11):840-851.
Buqué A, Bloy N, Petroni G, Kroemer G, Galluzzi L.  2020.  NK cells beat T cells at early breast cancer control.. Oncoimmunology. 9(1):1806010.
Chong SJun Fei, Marchi S, Petroni G, Kroemer G, Galluzzi L, Pervaiz S.  2020.  Noncanonical Cell Fate Regulation by Bcl-2 Proteins.. Trends Cell Biol. 30(7):537-555.
Fragliasso V, Verma A, Manzotti G, Tameni A, Bareja R, Heavican TB, Iqbal J, Wang R, Fiore D, Mularoni V et al..  2020.  The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK anaplastic large cell lymphoma by regulating the DNA helicase HELLS.. Leukemia. 34(11):2964-2980.
Kumar S, Warrell J, Li S, McGillivray PD, Meyerson W, Salichos L, Harmanci A, Martinez-Fundichely A, W Y Chan C, Nielsen MMuhlig et al..  2020.  Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences.. Cell. 180(5):915-927.e16.
Park K, Tran H, Eng KW, Ramazanoglu S, Rolon RMMarrero, Scognamiglio T, Borczuk A, Mosquera JMiguel, Pan Q, Sboner A et al..  2020.  Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.. Arch Pathol Lab Med. 144(12):1535-1546.
Mondanelli G, Coletti A, Greco FAntonio, Pallotta MTeresa, Orabona C, Iacono A, Belladonna MLaura, Albini E, Panfili E, Fallarino F et al..  2020.  Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.. Proc Natl Acad Sci U S A. 117(7):3848-3857.
Heymann JJ, Yoxtheimer LM, Park HJin, Fernandez EM, Facey KE, Alperstein SA, Tran HV, Baek I, Scognamiglio T, Rennert H et al..  2020.  Preanalytic variables in quality and quantity of nucleic acids extracted from FNA specimens of thyroid gland nodules collected in CytoLyt: Cellularity and storage time.. Cancer Cytopathol. 128(9):656-672.
Hajirasouliha I, Elemento O.  2020.  Precision medicine and artificial intelligence: overview and relevance to reproductive medicine.. Fertil Steril. 114(5):908-913.
Curchoe CLynn, Malmsten J, Bormann C, Shafiee H, Farias AFlores-Sai, Mendizabal G, Chavez-Badiola A, Sigaras A, Alshubbar H, Chambost J et al..  2020.  Predictive modeling in reproductive medicine: Where will the future of artificial intelligence research take us? Fertil Steril. 114(5):934-940.
Yamazaki T, Buqué A, Ames TD, Galluzzi L.  2020.  PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models.. Oncoimmunology. 9(1):1721810.
Segal E, Zhang F, Lin X, King G, Shalem O, Shilo S, Allen WE, Alquaddoomi F, Altae-Tran H, Anders S et al..  2020.  Publisher Correction: Building an international consortium for tracking coronavirus health status.. Nat Med. 26(8):1309.
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A et al..  2020.  Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.. Nat Commun. 11(1):4787.
Fizazi K, Kramer G, Eymard J-C, Sternberg CN, de Bono J, Castellano D, Tombal B, Wülfing C, Liontos M, Carles J et al..  2020.  Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.. Lancet Oncol. 21(11):1513-1525.